Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bind Therapeutics, Inc (BIND) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bind Therapeutics, Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1385228.
Total stock buying since 2016: $0.
Total stock sales since 2016: $0.
Total stock option exercises since 2016: $41,800.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2016 | 0 | $0 | 0 | $0 | 95,000 | $41,800 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2016-08 | 0 | $0 | 0 | $0 | 95,000 | $41,800 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-08-29 | Rowinsky Eric K (Director) | Option Ex | 15,000 | .44 | 6,600 |
| 2016-08-29 | Hutt Peter Barton (Director) | Option Ex | 15,000 | .44 | 6,600 |
| 2016-08-26 | Tzianabos Arthur (Director) | Option Ex | 15,000 | .44 | 6,600 |
| 2016-08-26 | Rowland Charles A Jr (Director) | Option Ex | 15,000 | .44 | 6,600 |
| 2016-08-26 | Langer Robert (Director) | Option Ex | 15,000 | .44 | 6,600 |
| 2016-08-26 | Lynch Daniel (Director) | Option Ex | 20,000 | .44 | 8,800 |
Insider trading activities including stock purchases, stock sales, and option exercises of BIND listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bind Therapeutics, Inc (symbol BIND, CIK number 1385228) see the Securities and Exchange Commission (SEC) website.